Synopsis
Viral clearance services refer to viral removal or viral inactivation service. Viral clearance studies are a critical element toward ensuring that an acceptable level of viral safety has been achieved for biological products. The goal of these studies is to demonstrate that the manufacturing purification process has the ability to inactivate and/or remove viruses that are known to contaminate or which may possibly contaminate the starting materials, as well as additional viruses that are models for a broad variety of viruses. Viral clearance studies provide a complementary strategy to direct testing of cell banks, raw materials and bioreactor harvests, which may not detect all viruses that could potentially contaminate the product.
The global Viral Clearance market size is expected to reach US$ 780.3 million by 2029, growing at a CAGR of 9.5% from 2023 to 2029. The market is mainly driven by the significant applications of Viral Clearance in various end use industries. The expanding demands from the Recombinant Proteins, Blood and Blood Products, Vaccines and Other Applications, are propelling Viral Clearance market. Viral Removal, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chromatography segment is estimated at % CAGR for the next seven-year period.
North America is the largest Viral Clearance Service market with about 51% market share. Europe is follower, accounting for about 23% market share.The key manufacturers are Charles River, BioReliance (Merck), Eurofins Scientific, Sartorius, Covance, ViruSure, Texcell, Bioscience Labs, Vironova Biosafety, Mérieux NutriSciences, WuXi AppTec, Syngene, Labor Dr. Merk etc. Top 3 companies occupied about 39% market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Clearance, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Clearance market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Clearance market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Clearance sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Clearance covered in this report include Wuxi Biologics (Cayman), Merck, Charles River Laboratories International, Kedrion, Vironova Biosafety, Texcell and Clean Cells, etc.
The global Viral Clearance market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Wuxi Biologics (Cayman)
Merck
Charles River Laboratories International
Kedrion
Vironova Biosafety
Texcell
Clean Cells
Global Viral Clearance market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Clearance market, Segment by Type:
Viral Removal
Chromatography
Nanofiltration
Precipitation
Viral Inactivation
Low pH
Solvent Detergent Method
Pasteurization
Other Viral Inactivation Methods
Global Viral Clearance market, by Application
Recombinant Proteins
Blood and Blood Products
Vaccines
Other Applications
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Clearance companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Viral Clearance
1.1 Viral Clearance Market Overview
1.1.1 Viral Clearance Product Scope
1.1.2 Viral Clearance Market Status and Outlook
1.2 Global Viral Clearance Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Viral Clearance Market Size by Region (2018-2029)
1.4 Global Viral Clearance Historic Market Size by Region (2018-2023)
1.5 Global Viral Clearance Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Viral Clearance Market Size (2018-2029)
1.6.1 North America Viral Clearance Market Size (2018-2029)
1.6.2 Europe Viral Clearance Market Size (2018-2029)
1.6.3 Asia-Pacific Viral Clearance Market Size (2018-2029)
1.6.4 Latin America Viral Clearance Market Size (2018-2029)
1.6.5 Middle East & Africa Viral Clearance Market Size (2018-2029)
2 Viral Clearance Market by Type
2.1 Introduction
2.1.1 Viral Removal
2.1.2 Chromatography
2.1.3 Nanofiltration
2.1.4 Precipitation
2.1.5 Viral Inactivation
2.1.6 Low pH
2.1.7 Solvent Detergent Method
2.1.8 Pasteurization
2.1.9 Other Viral Inactivation Methods
2.2 Global Viral Clearance Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Viral Clearance Historic Market Size by Type (2018-2023)
2.2.2 Global Viral Clearance Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Viral Clearance Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Viral Clearance Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Viral Clearance Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Viral Clearance Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Viral Clearance Revenue Breakdown by Type (2018-2029)
3 Viral Clearance Market Overview by Application
3.1 Introduction
3.1.1 Recombinant Proteins
3.1.2 Blood and Blood Products
3.1.3 Vaccines
3.1.4 Other Applications
3.2 Global Viral Clearance Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Viral Clearance Historic Market Size by Application (2018-2023)
3.2.2 Global Viral Clearance Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Viral Clearance Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Viral Clearance Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Viral Clearance Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Viral Clearance Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Viral Clearance Revenue Breakdown by Application (2018-2029)
4 Viral Clearance Competition Analysis by Players
4.1 Global Viral Clearance Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Clearance as of 2022)
4.3 Date of Key Players Enter into Viral Clearance Market
4.4 Global Top Players Viral Clearance Headquarters and Area Served
4.5 Key Players Viral Clearance Product Solution and Service
4.6 Competitive Status
4.6.1 Viral Clearance Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Wuxi Biologics (Cayman)
5.1.1 Wuxi Biologics (Cayman) Profile
5.1.2 Wuxi Biologics (Cayman) Main Business
5.1.3 Wuxi Biologics (Cayman) Viral Clearance Products, Services and Solutions
5.1.4 Wuxi Biologics (Cayman) Viral Clearance Revenue (US$ Million) & (2018-2023)
5.1.5 Wuxi Biologics (Cayman) Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Viral Clearance Products, Services and Solutions
5.2.4 Merck Viral Clearance Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Charles River Laboratories International
5.3.1 Charles River Laboratories International Profile
5.3.2 Charles River Laboratories International Main Business
5.3.3 Charles River Laboratories International Viral Clearance Products, Services and Solutions
5.3.4 Charles River Laboratories International Viral Clearance Revenue (US$ Million) & (2018-2023)
5.3.5 Kedrion Recent Developments
5.4 Kedrion
5.4.1 Kedrion Profile
5.4.2 Kedrion Main Business
5.4.3 Kedrion Viral Clearance Products, Services and Solutions
5.4.4 Kedrion Viral Clearance Revenue (US$ Million) & (2018-2023)
5.4.5 Kedrion Recent Developments
5.5 Vironova Biosafety
5.5.1 Vironova Biosafety Profile
5.5.2 Vironova Biosafety Main Business
5.5.3 Vironova Biosafety Viral Clearance Products, Services and Solutions
5.5.4 Vironova Biosafety Viral Clearance Revenue (US$ Million) & (2018-2023)
5.5.5 Vironova Biosafety Recent Developments
5.6 Texcell
5.6.1 Texcell Profile
5.6.2 Texcell Main Business
5.6.3 Texcell Viral Clearance Products, Services and Solutions
5.6.4 Texcell Viral Clearance Revenue (US$ Million) & (2018-2023)
5.6.5 Texcell Recent Developments
5.7 Clean Cells
5.7.1 Clean Cells Profile
5.7.2 Clean Cells Main Business
5.7.3 Clean Cells Viral Clearance Products, Services and Solutions
5.7.4 Clean Cells Viral Clearance Revenue (US$ Million) & (2018-2023)
5.7.5 Clean Cells Recent Developments
6 North America
6.1 North America Viral Clearance Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Viral Clearance Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Viral Clearance Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Viral Clearance Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Viral Clearance Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Viral Clearance Market Dynamics
11.1 Viral Clearance Industry Trends
11.2 Viral Clearance Market Drivers
11.3 Viral Clearance Market Challenges
11.4 Viral Clearance Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List